Cargando…
Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study
BACKGROUND: With ever-increasing demand for total knee arthroplasty (TKA), most healthcare systems around the world are concerned about its socioeconomic burden. Most centers have universally adopted well-defined clinical care pathways to minimize adverse outcomes, maximize volume, and limit costs....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Orthopaedic Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858904/ https://www.ncbi.nlm.nih.gov/pubmed/35251542 http://dx.doi.org/10.4055/cios20234 |
_version_ | 1784654333575430144 |
---|---|
author | Kulshrestha, Vikas Sood, Munish Kumar, Santhosh Sood, Nikhil Kumar, Pradeep Padhi, Prashanth P |
author_facet | Kulshrestha, Vikas Sood, Munish Kumar, Santhosh Sood, Nikhil Kumar, Pradeep Padhi, Prashanth P |
author_sort | Kulshrestha, Vikas |
collection | PubMed |
description | BACKGROUND: With ever-increasing demand for total knee arthroplasty (TKA), most healthcare systems around the world are concerned about its socioeconomic burden. Most centers have universally adopted well-defined clinical care pathways to minimize adverse outcomes, maximize volume, and limit costs. However, there are no prospective comparative trials reporting benefits of these risk mitigation (RM) strategies. METHODS: This is a prospective cohort study comparing post-TKA 90-day complications between patients undergoing RM before surgery and those following a standard protocol (SP). In the RM group, we used a 20-point checklist to screen for modifiable risk factors and evaluate the need for optimizing non-modifiable comorbidities. Only when optimization goals were achieved, patients were offered TKA. RESULTS: TKA was performed in 811 patients in the SP group and in 829 in the RM group, 40% of which were simultaneous bilateral TKA. In both groups, hypertension was the most prevalent comorbidity (48%), followed by diabetes (20%). A total of 43 (5.3%) procedure-related complications were seen over the 90-day postoperative period in the SP group, which was significantly greater than 26 (3.1%) seen in the RM group (p = 0.039). The commonest complication was pulmonary thromboembolic, 6 in each group. Blood transfusion rate was higher in the SP group (6%) than in the RM group (< 1%). CONCLUSIONS: Screening and RM can reduce 90-day complications in patients undergoing TKA. |
format | Online Article Text |
id | pubmed-8858904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Orthopaedic Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-88589042022-03-03 Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study Kulshrestha, Vikas Sood, Munish Kumar, Santhosh Sood, Nikhil Kumar, Pradeep Padhi, Prashanth P Clin Orthop Surg Original Article BACKGROUND: With ever-increasing demand for total knee arthroplasty (TKA), most healthcare systems around the world are concerned about its socioeconomic burden. Most centers have universally adopted well-defined clinical care pathways to minimize adverse outcomes, maximize volume, and limit costs. However, there are no prospective comparative trials reporting benefits of these risk mitigation (RM) strategies. METHODS: This is a prospective cohort study comparing post-TKA 90-day complications between patients undergoing RM before surgery and those following a standard protocol (SP). In the RM group, we used a 20-point checklist to screen for modifiable risk factors and evaluate the need for optimizing non-modifiable comorbidities. Only when optimization goals were achieved, patients were offered TKA. RESULTS: TKA was performed in 811 patients in the SP group and in 829 in the RM group, 40% of which were simultaneous bilateral TKA. In both groups, hypertension was the most prevalent comorbidity (48%), followed by diabetes (20%). A total of 43 (5.3%) procedure-related complications were seen over the 90-day postoperative period in the SP group, which was significantly greater than 26 (3.1%) seen in the RM group (p = 0.039). The commonest complication was pulmonary thromboembolic, 6 in each group. Blood transfusion rate was higher in the SP group (6%) than in the RM group (< 1%). CONCLUSIONS: Screening and RM can reduce 90-day complications in patients undergoing TKA. The Korean Orthopaedic Association 2022-03 2022-01-14 /pmc/articles/PMC8858904/ /pubmed/35251542 http://dx.doi.org/10.4055/cios20234 Text en Copyright © 2022 by The Korean Orthopaedic Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kulshrestha, Vikas Sood, Munish Kumar, Santhosh Sood, Nikhil Kumar, Pradeep Padhi, Prashanth P Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study |
title | Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study |
title_full | Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study |
title_fullStr | Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study |
title_full_unstemmed | Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study |
title_short | Does Risk Mitigation Reduce 90-Day Complications in Patients Undergoing Total Knee Arthroplasty?: A Cohort Study |
title_sort | does risk mitigation reduce 90-day complications in patients undergoing total knee arthroplasty?: a cohort study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858904/ https://www.ncbi.nlm.nih.gov/pubmed/35251542 http://dx.doi.org/10.4055/cios20234 |
work_keys_str_mv | AT kulshresthavikas doesriskmitigationreduce90daycomplicationsinpatientsundergoingtotalkneearthroplastyacohortstudy AT soodmunish doesriskmitigationreduce90daycomplicationsinpatientsundergoingtotalkneearthroplastyacohortstudy AT kumarsanthosh doesriskmitigationreduce90daycomplicationsinpatientsundergoingtotalkneearthroplastyacohortstudy AT soodnikhil doesriskmitigationreduce90daycomplicationsinpatientsundergoingtotalkneearthroplastyacohortstudy AT kumarpradeep doesriskmitigationreduce90daycomplicationsinpatientsundergoingtotalkneearthroplastyacohortstudy AT padhiprashanthp doesriskmitigationreduce90daycomplicationsinpatientsundergoingtotalkneearthroplastyacohortstudy |